Full Text View
Tabular View
No Study Results Posted
Related Studies
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism
This study has been completed.
Study NCT00290134   Information provided by QuatRx Pharmaceuticals Company

First Received on February 9, 2006.   Last Updated on February 29, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypogonadism
More general conditions related to this trial
Endocrine System Diseases
Gonadal Disorders
Interventions listed in this trial
Fispemifene once daily for 4 weeks
Additional drug interventions recognized in this trial
Tamoxifen
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
QuatRx Pharmaceuticals Company
Hormos Medical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services